The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
P504S: A New Molecular Marker for the Detection of Prostate Carcinoma
Abstract
The ability to diagnose prostate carcinoma would be improved by the detection of a tumor-associated antigen. P504S, a cytoplasmic protein, was recently identified by cDNA library subtraction in conjunction with high throughput microarray screening from prostate carcinoma. The aim of this study was to establish the pattern of expression of P504S in prostate carcinoma and benign prostatic tissue. A total of 207 cases, including 137 cases of prostate carcinoma and 70 cases of benign prostate, from prostatectomies (n = 77), prostate needle biopsies (n = 112), and transurethral prostate resections (n = 18) were examined by immunocytochemistry for P504S. P504S showed strong cytoplasmic granular staining in 100% of prostate carcinomas regardless of Gleason scores and diffuse (>75% of tumor) staining in 92% of cases. In contrast, 171 of 194 (88%) of benign prostates, including 56 of 67 (84%) benign prostate cases and 115 of 127 (91%) cases of benign glands adjacent to cancers were negative for P504S. The remainders of benign prostates were focally and weakly positive for P504S. The staining pattern of these normal glands was different and easily distinguishable from that observed in prostate carcinoma. Expression of P504S was not found in basal cell hyperplasia, urothelial cells/metaplasia and small atrophic glands that may mimic prostate carcinoma. Our findings indicate that P504S is a highly sensitive and specific positive marker for prostate carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
Israeli, R., Powell, C. T., Fair, W. R., & Heston, W. D. W. (1993) · PubMed · Cited by 541
Gown, A. M., & VOGEL, A. M. (1984) · PubMed · Cited by 404
The Clinical Usefulness of Prostate Specific Antigen: Update 1994
Partin, A. W., & Oesterling, J. E. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32422-9 · Cited by 390
Xu, J., Stolk, J. A., Zhang, X., Silva, S. J., Houghton, R. L., Matsumura, M., Vedvick, T. S., Leslie, K. B., Badaró, R. J. D. S., & Reed, S. G. (2000) · PubMed · Cited by 343
Self-citationSubcellular localization and physiological role of α-methylacyl-CoA racemase
Ferdinandusse, S., Denis, S., IJlst, L., Dacremont, G., Waterham, H. R., & Wanders, R. J. A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31983-0 · Cited by 184
Babcook, J. S., Leslie, K. B., Olsen, O. A., Salmon, R. A., & Schrader, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7843 · Cited by 132
Self-citationEdwards, J., Anderson, N. G., Tollaksen, S. L., von Eschenbach, A. C., & Guevara, J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.1.160 · Cited by 68
A Simplified Purification Procedure for Human Prostate Antigen
Wang, M. C., Valenzuela, L., Murphy, G. P., & Chu, M. (2009) · Oncology · doi:10.1159/000225594 · Cited by 66
12‐Lipoxygenase, 12(S)‐HETE, and Cancer Metastasisa
Tang, D. G., & Honn, K. V. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb52738.x · Cited by 60
Cited by
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Massie, C. E., Lynch, A., Ramos‐Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.158 · Cited by 624
Autoantibody Signatures in Prostate Cancer
Wang, X., Yu, J., Sreekumar, A., Varambally, S., Shen, R., Giacherio, D., Mehra, R., Montie, J. E., Pienta, K. J., Sanda, M. G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051931 · Cited by 582
Pathological and molecular aspects of prostate cancer
DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., & Epstein, J. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12779-1 · Cited by 472
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Metadata
- Authors
- Jiang, Z., Woda, B. A., Rock, K. L., Xu, Y., Savas, L., Khan, A., Pihan, G., Cai, F., Babcook, J. S., Rathanaswami, P., Reed, S. G., Xu, J., & Fanger, G. R.
- Venue
- The American Journal of Surgical Pathology
- Published
- 2001-11
- Volume
- 25
- Issue
- 11
- Pages
- 1397-1404
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W1966056172
- Cited by
- 365
- References
- 10
- FWCI
- 21.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: P504S: A New Molecular Marker for the Detection of Prostate Carcinoma. https://app.cochat.ai/papers/10.1097/00000478-200111000-00007
- The paper
- Jiang, Z., Woda, B. A., Rock, K. L., Xu, Y., Savas, L., Khan, A., Pihan, G., Cai, F., Babcook, J. S., Rathanaswami, P., Reed, S. G., Xu, J., & Fanger, G. R. (2001). P504S: A New Molecular Marker for the Detection of Prostate Carcinoma. The American Journal of Surgical Pathology. https://doi.org/10.1097/00000478-200111000-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.